The detection of anal squamous cell cancer precursors with high-resolution anoscopy (HRA) poses a medical challenge, with a significant subset of lesions often missed. At DIGESTAID, we’re thrilled to announce our latest breakthrough in this field. Published in Clinical and Translational Gastroenterology (Q1 official journal of the American College of Gastroenterology), our recent study sheds light on the efficacy of Anoscopy Genius® in addressing this challenge.

Our research demonstrates promising results, showing excellent diagnostic performance at various staining settings. With this pivotal advancement, we’re confident that AI-powered HRA will revolutionize patient prognosis, enabling early and precise diagnoses. Join us in our mission to enhance healthcare outcomes and fight anal cancer.